Anhui Genuine New Materials (603429.SH) plans to acquire over 50% of the equity of Huiju Pharmaceutical Company.

Anhui Genuine New Materials (603429.SH) announced that the company plans to purchase over 50% of the shares of Jiangsu Huiju Pharmaceutical Co., Ltd. ("Huiju Pharmaceutical") in cash and obtain control of the target company. After the completion of this transaction, the target company will become a subsidiary of the company. After this transaction is completed, the target company will become a subsidiary of the company, which will help the company expand new profit growth points, enhance the company's sustainable operation capability, improve core competitiveness, effectively protect the interests of the company's shareholders, and align with the company's strategic development plan.